Multiple Sclerosis, or MS, is a progressive disease that targets the central nervous system. Early symptoms include fatigue, vision problems, numbness, dizziness, muscle weakness, and imbalance.
People at any age can get this disease, but it usually affects people aged 20 to 40 years old. Additionally, those who live in colder climates are particularly at risk.
The Multiple Sclerosis Foundation reports that there are over 2.5 million people worldwide who have been diagnosed with MS. Canada, San Marino, Denmark, Sweden and U.K. are among the top countries that have the highest number of MS cases.
There’s no cure at present, and fortunately, a new study has shown that a new drug slows decline in progressive MS. More information is discussed in this article on BBC News:
First drug ‘slows decline’ in progressive MS
The disease affects nerves and leads to fatigue, muscle problems and loss of vision.
Preliminary data from trials of 732 people showed that ocrelizumab slowed the onset of disability by 24% over the course of 12 weeks.
The MS Society said the findings were a “big moment” in treating the disease. Read more…
Although this drug slows decline in progressive MS, it doesn’t treat it. But this is a good discovery. They should really make the drug affordable even though we all know that MS is an expensive disease to treat. In the US, the health care costs are around $8,500 to $54,200.
Hopefully they will discover the cure shortly.
Image Credit: First drug ‘slows decline’ in progressive MS – BBC News
The post New Drug Slows Decline in Progressive MS appeared first on NUTRITIONCLUB.
No comments:
Post a Comment